Pursuant to section 70e (3), (4) and (6) of the Transport Act 1962, a delegation from the Land Transport Safety Authority and a sub-delegation from the Director of Land Transport Safety dated the 30th day of June 1994, I, John Paul Edgar, Manager Policy and Programmes, Safer Vehicles Road and Rail, give the following notice: N o t i c e The ``prescribed standard'' referred to in section 70f (3) (b), (c) and (d) of the Transport Act 1962 shall be the standard described in the First Schedule as modified by the Second Schedule. First Schedule Prescribed Standard New Zealand Standard 5433 : 1988 entitled Code of Practice for the Transport of Hazardous Substances on Land. Second Schedule The prescribed Standard shall be amended as per Amendment No. 2 issued by Standards New Zealand in February 1994. The prescribed Standard shall be modified in section 3.2.6.1 (b) by removing the text : Substances containing viable micro-organisms or their toxins which are known, or suspected, to cause disease in animals or humans. NOTE - ``Biological products'' and ``Diagnostic specimens'' are not considered to be dangerous goods provided they do not contain, or are reasonably believed not to contain, an infectious substance or do not contain any other dangerous substance. then inserting the text: These are substances containing viable micro-organisms, including a bacterium, virus, rickettsia, parasite, fungus, or a recombinant, hybrid or mutant, or their toxins which are known or reasonably believed to cause disease in animals and humans. With the exclusion of live animal and human vaccines, all biological products and diagnostic specimens must be treated as Class 6.2 Infectious Substances unless known not to contain an infectious substance or any other dangerous substance. Note # Biological Products Those substances which meet one of the following criteria: finished biological products for human or veterinary use manufactured in accordance with the requirements of national public health authorities and moving under special approval or licence from such authorities; finished biological products shipped prior to licensing for development or investigational purposes for use in humans or animals; finished biological products for experimental treatment of animals; and which are manufactured in compliance with the requirements of national public health authorities. They also cover unfinished biological products prepared in accordance with procedures of specialised governmental agencies. Live animal and human vaccines are considered biological products and not infectious substances. # Diagnostic Specimens Any human or animal material including, but not limited to, excreta, secreta, blood and its components, tissue and tissue fluids, being shipped for purposes of diagnosis, but excluding live infected animals. # Wastes classified as UN 3291 wastes derived from the medical treatment of animals or human or from biological research which are unlikely to contain substances of class 6.2. Decontaminated clinical wastes or decontaminated wastes resulting from clinical research which previously contained infectious substances are not classified as Class 6.2. The prescribed standard shall be modified in Section 7.2.6 by removing the text: ``Class 6.1 and 8 substances'' and inserting the text: ``Class 6 and 8 substances'' The prescribed standard shall be modified in Section 10.1 by inserting the text [tn,4] Substance UN No. Class Packaging Group [tn,4] CLINICAL WASTE UNSPECIFIED, N.O.S.; or (BIO) MEDICAL WASTE, N.O.S.; or REGULATED MEDICAL WASTE, N.O.S. 3291 6.2 II [tn,4] Signed at Wellington this 9th day of December 1994. J. P. EDGAR, Manager Policy and Programmes, Safer Vehicles Road and Rail. (RT21/9)